Komori
Japan Pure Chemical (4973) · InitiativeReframedLatest Share Issuance and Disposal (2026-07-17): "Advanced"

Issuance of Stock Acquisition Rights for Directors, Audit and Supervisory Board Members, and Employees

First written in FY2017-Q2. 20 of 24 entries say "Advanced", first in FY2017. Latest entry: 2026-07-17.

24entries
11years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017 – 2026-06-022016: 12017: 320172018: 220182019: 220192020: 220202021: 220212022: 220222023: 220232024: 220242025: 220252026: 42026
Same theme, other companies
Discontinuation of Share-Based Compensation Stock Options and Transition to Restricted Stock CompensationA theme 39 companies write about · 0 as a headwind · 41 as a tailwind

16 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 39 companies compared. The sentences above are computed from all 39.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「Following the allocation of the 22nd Stock Acquisition Rights, the company abolished the provisions for tax-qualified stock options for directors, excluding outside directors, and will no longer allocate stock acquisition rights to directors, excluding outside directors, as tax-qualified stock options.」

    Following the 22nd Stock Acquisition Rights, the company abolished tax-qualified stock options for directors and restructured its stock compensation plan around restricted stock compensation.
  2. 2026-06-02AdvancedGeneral Meetings of Shareholders

    「Status of stock acquisition rights granted to company employees during the fiscal year as consideration for the performance of their duties Resolution date 20 June 2025 Number of people 50 Number of stock acquisition rights 179 Class and number of shares underlying the rights 17,900 common shares」

    Recorded the grant of 179 stock acquisition rights to 50 employees, representing 17,900 common shares.
  3. FY2026-H1AdvancedAnnual report

    「22nd Stock Acquisition Rights Resolution date 20 June 2025 Eligible recipients and number 3 directors and 50 employees Number of stock acquisition rights※ 249 Class, description and number of shares underlying the stock acquisition rights※ Ordinary shares: 24,900 shares Exercise period for the stock acquisition rights※ 1 July 2027 to 30 June 2030」

    The company issued 249 22nd Stock Acquisition Rights covering 24,900 ordinary shares to 3 directors and 50 employees, and set an exercise period from 1 July 2027 to 30 June 2030.
  4. FY2025AdvancedAnnual report

    「During the fiscal year, 15,200 shares were acquired through the exercise of stock options, bringing treasury shares held to 290,707.」

    The exercise of stock options covering 15,200 shares and the disposal of treasury shares progressed, expanding the scale of execution from the exercise of 1,000 shares in the previous year.
  5. FY2025-H1AdvancedAnnual report

    「21st Stock Acquisition Rights Resolution date 25 June 2024 Eligible recipients and number 3 directors and 47 employees Number of stock acquisition rights※ 237 Class, description and number of shares underlying the stock acquisition rights※ Ordinary shares: 23,700 shares Exercise period for the stock acquisition rights※ 1 July 2026 to 30 June 2029」

    The company issued 237 21st Stock Acquisition Rights covering 23,700 ordinary shares to 3 directors and 47 employees, and set an exercise period from 1 July 2026 to 30 June 2029.
  6. FY2024AdvancedAnnual report

    「During the fiscal year, 1,000 shares were acquired through the exercise of stock options, bringing treasury shares held to 310,133.」Other (disposal of treasury shares under the restricted stock compensation plan): 5,200」

    The company carried out the exercise of stock options covering 1,000 shares and disposed of 5,200 treasury shares under the restricted stock compensation plan.
  7. FY2024-Q2AdvancedAnnual report

    「20th Stock Acquisition Rights Resolution date 20 June 2023 Eligible recipients and number 3 directors and 45 employees Number of stock acquisition rights※ 231 Class, description and number of shares underlying the stock acquisition rights※ Ordinary shares: 23,100 shares Exercise period for the stock acquisition rights※ 1 July 2025 to 30 June 2028」

    The company issued 231 20th Stock Acquisition Rights covering 23,100 ordinary shares to 3 directors and 45 employees. The exercise period is from 1 July 2025 to 30 June 2028.
  8. FY2023AdvancedAnnual report

    「During the fiscal year, 7,500 shares were acquired through the exercise of stock options, bringing treasury shares held to 316,287.」“19th Stock Acquisition Rights”「Ordinary shares: 24,000 shares」

    The grant of the 19th Stock Acquisition Rights covering 24,000 shares was confirmed, and 7,500 stock option shares were exercised during the fiscal year.
  9. FY2023-Q2AdvancedAnnual report

    「19th Stock Acquisition Rights Resolution date 17 June 2022 Eligible recipients and number 3 directors and 43 employees Number of stock acquisition rights※ 240 Class, description and number of shares underlying the stock acquisition rights※ Ordinary shares: 24,000 shares Exercise period for the stock acquisition rights※ 1 July 2024 to 30 June 2027」

    The company granted 240 19th Stock Acquisition Rights covering 24,000 ordinary shares to 3 directors and 43 employees, with an exercise period from 1 July 2024 to 30 June 2027.
  10. FY2022AdvancedAnnual report

    「During the fiscal year, 51,800 shares were acquired through the exercise of stock options, bringing treasury shares held to 462,819.」

    During the fiscal year, 51,800 stock option shares were exercised. The company also disclosed a grant of the 18th Stock Acquisition Rights covering 20,900 shares.
  11. FY2022-Q2AdvancedAnnual report

    「18th Stock Acquisition Rights Resolution date 18 June 2021 Eligible recipients and number 3 directors and 45 employees Number of stock acquisition rights※ 209 Class, description and number of shares underlying the stock acquisition rights※ Ordinary shares: 20,900 shares Exercise period for the stock acquisition rights※ 1 July 2023 to 30 June 2026」

    The company issued 209 18th Stock Acquisition Rights covering 20,900 ordinary shares to 3 directors and 45 employees. It also disclosed an exercise period from 1 July 2023 to 30 June 2026.
  12. FY2021AdvancedAnnual report

    「During the fiscal year, 16,800 shares were acquired through the exercise of stock options, bringing treasury shares held to 520,283.」

    During the fiscal year, stock options covering 16,800 shares were exercised, and the disposal of treasury shares progressed.
  13. FY2021-Q2AdvancedAnnual report

    「The stock acquisition rights issued during the second quarter accounting period were as follows.」Eligible recipients and number: 5 directors「Number of stock acquisition rights: 102「Ordinary shares: 10,200 shares」Eligible recipients and number: 7 directors and 44 employees「Number of stock acquisition rights: 278「Ordinary shares: 27,800 shares」

    Based on the resolution dated 19 June 2020, the company issued 102 stock acquisition rights covering 10,200 shares to 5 directors, and 278 stock acquisition rights covering 27,800 shares to 7 directors and 44 employees.
  14. FY2020AdvancedAnnual report

    「During the fiscal year, 8,700 shares were acquired through the exercise of stock options, bringing treasury shares held to 537,000.」“2019 Stock Acquisition Rights”「Ordinary shares: 13,500 shares」

    During the fiscal year, stock options covering 8,700 shares were exercised, and the disposal of treasury shares progressed. In addition, rights covering 13,500 shares were granted as the 2019 Stock Acquisition Rights.
  15. FY2020-Q2AdvancedAnnual report

    「The stock acquisition rights issued during the second-quarter accounting period were as follows.” “Eligible recipients and number: Directors, 5 people” “Number of stock acquisition rights: 135” “Common shares: 13,500 shares” “Number of stock acquisition rights: 291” “Common shares: 29,100 shares」

    Based on the resolution dated 21 June 2019, the company issued 135 stock acquisition rights covering 13,500 shares to 5 directors, and 291 stock acquisition rights covering 29,100 shares to 7 directors and 45 employees.
  16. FY2019AdvancedAnnual report

    「During the fiscal year, 13,600 shares were acquired through the exercise of stock options, resulting in the Company holding 545,640 treasury shares.」

    Stock options were exercised for 13,600 shares during the fiscal year, progressing the disposition of treasury shares.
  17. FY2019-Q2AdvancedAnnual report

    「The stock acquisition rights issued during the second-quarter accounting period were as follows.” “Number of stock acquisition rights ※ 129” “Class, description and number of shares underlying the stock acquisition rights ※ common shares 12,900 shares” “Number of stock acquisition rights 291” “Class, description and number of shares underlying the stock acquisition rights ※ common shares 29,100 shares”」

    Based on the resolution adopted on 15 June 2018, the Company issued 129 stock acquisition rights for 12,900 shares to directors and 291 stock acquisition rights for 29,100 shares to directors and employees.
  18. FY2018AdvancedAnnual report

    「During the fiscal year, 13,600 shares were acquired through the exercise of stock options, resulting in the Company holding 559,200 treasury shares.」

    Existing stock options were exercised for 13,600 shares during the fiscal year, progressing the disposition of treasury shares.
  19. FY2018-Q2AdvancedAnnual report

    「The stock acquisition rights issued during the second-quarter accounting period were as follows.” “Number of stock acquisition rights 142” “Number of shares underlying the stock acquisition rights 14,200 shares” “Number of stock acquisition rights 297” “Number of shares underlying the stock acquisition rights 29,700 shares”」

    The Company actually issued 142 stock acquisition rights for 14,200 shares to directors and 297 stock acquisition rights for 29,700 shares to directors, audit & supervisory board members and employees.
  20. FY2017AdvancedAnnual report

    「Other (exercise of stock options) 29,900 68,025” The Company resolved at a meeting of its Board of Directors held on 16 June 2017 to issue stock options in the form of share-based compensation for directors, as follows.」

    The disclosure reported the disposition of 29,900 treasury shares through the exercise of existing stock options and also described resolutions adopted after the filing date concerning new issuances for directors, and for directors and employees.
  21. FY2017-Q3Existing stock acquisition rights became dilutiveAnnual report

    「The 11th series of stock acquisition rights (approved at the general meeting of shareholders held on 20 June 2014, for 26,700 shares) became dilutive.」

    No new stock acquisition rights were issued; rather, the existing 11th series of stock acquisition rights became dilutive for purposes of calculating diluted earnings per share.
  22. FY2017-Q2First statedAnnual report

    「Number of stock acquisition rights 139 Number of shares underlying the stock acquisition rights 13,900 shares Exercise period for the stock acquisition rights 5 July 2016 to 4 July 2046 Number of stock acquisition rights 290 Number of shares underlying the stock acquisition rights 29,000 shares Exercise period for the stock acquisition rights 4 July 2018 to 3 July 2021」

    During the second-quarter accounting period, 2 types of stock acquisition rights were issued, one for directors and one for directors, audit & supervisory board members and employees.
Moved together

"Research and development driven by the two pillars of software technology and materials technology" moved the same way as this thread, in the same document, in 8 of its 24 moves.

876665★123456
  1. ★This thread
  2. 1Research and development driven by the two pillars of software technology and materials technology8×
  3. 2Market Testing and Customer Evaluation of Gold-Reduced and Precious-Metal-Free Products7×
  4. 3Sharing Value with Shareholders through Restricted Stock Compensation6×
  5. 4Solder Ball Alternatives and Nano-Scale Plating Technologies6×
  6. 5Acquisition of New Measuring Equipment, etc.6×
  7. 6Internal Control and Enterprise-Wide Risk Management Framework5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Japan Pure Chemical's next results are scheduled for 2026-10-27. Read the earnings preview It last moved in the Share Issuance and Disposal of 2026-07-17: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.